FIONA ELSEY IDENTIFIES IMMUNE MECHANISM
Researchers at the Fiona Elsey Cancer Research Institute have made progress in understanding how a specific type of immune cell is involved in the development of lesions associated with Langerhans Cell Histiocytosis (LCH). This research has been recently recognised and published in international medical journal, Clinical Immunology. It is hoped that these findings will lead to a better way to treat patients with LCH. LCH is a rare type of cancer, mostly found in children. It results in lesions forming in any organ, which can lead to organ dysfunction and permanent damage. To read further information, CLICK HERE.